Our study discovered that the TRAF3IP3 high-expression group exhibited elevated levels of immune checkpoint expression, suggesting that TRAF3IP3 could be a reliable predictor of immune checkpoint expression in HCC. This evidence concerns the gene TRAF3IP3 and hepatocellular carcinoma.